SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950162-09-000085
Filing Date
2009-02-20
Accepted
2009-02-20 14:07:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA/PAOLO CAVAZZA SCHEDULE 13D - 02/11/09 paolo13d_021109.htm SC 13D 236516
  Complete submission text file 0000950162-09-000085.txt   238433
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-39976 | Film No.: 09624531
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address VIA SUDAFRICA, 20 ROME A1 00000
CAVAZZA PAOLO (Filed by) CIK: 0001163608 (see all company filings)

Type: SC 13D